August 28, 2013 — VuComp Inc. announced it has installed its advanced computer-aided detection (CAD) system, M-Vu CAD, at Allison Breast Center in Richmond, Va. The VuComp system, the first of its kind in Virginia, will analyze images from the clinic’s new Philips MicroDose Mammography system. Women in the region will have access to the world’s most advanced tools to help detect breast cancer as early as possible in order to achieve the best outcomes. VuComp’s M-Vu system analyzes mammographic images and marks suspicious areas using sophisticated mathematical algorithms.

“Our experience with VuComp’s CAD system has been extremely satisfactory in that it does not overcall and certainly is very sensitive to real abnormalities,” said Michael Bigg, M.D., JD, chief radiologist and owner of Allison Breast Center. “Earlier CAD systems with older software technology, which are still widely in use, certainly flag far too many abnormalities, reducing diagnostic confidence and wasting time.”

Bigg noted that VuComp CAD has also been an important aid in helping patients understand their situation — and in gaining their confidence. “Surprisingly, not all patients when shown an abnormality on a mammogram are comfortable with proceeding to an immediate biopsy, especially when these are small and more subtle. I spend a lot of time convincing reluctant patients of the need for biopsy. I’ve found that when I point out VuComp’s CAD marks on their mammogram it helps them to understand and become more comfortable with the recommendation.”

The VuComp system received U.S. Food and Drug Administration (FDA) approval to work with film mammography systems in January 2012, and a supplementary approval for digital mammography in October 2012. While CAD systems have been used in clinical practice since the mid-1990s, recent FDA guidelines have significantly raised the bar for CAD performance and now recommend comprehensive reader studies proving that radiologists are more effective when they use CAD. The VuComp system is the only FDA-approved mammography CAD product that meets these recommendations.

For more information: www.vucomp.com


Related Content

News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now